320 TUESDAY • MAY 17 3:20 Pediatric Pulmonary Hypertension Guidelines S.H. Abman, MD, Aurora, CO 3:35 Pediatric Bronchoscopy Technical Standards A. Faro, MD, St. Louis, MO 3:50 Late Breaking Guidelines K.C. Wilson, MD, New York, NY C93 There will be a 5-minute discussion after each talk. MINI SYMPOSIUM IMMUNE REGULATION OF INFECTION: BUILT IN PROTECTION 2:15 p.m. - 4:15 p.m. MOSCONE CENTER Chairing: M.A. Olman, MA MD, Cleveland, OH J.K. Kolls, MD, Pittsburgh, PA J.C. Deng, MD, Los Angeles, CA Oral Presentations Room 3020/3022 (West Building, Level 3) 2:15 Resolvin D1 Promotes Nontypeable Haemophilus Influenzae Clearance and Improves Respiratory Health/A. Croasdell, S.H. Lacy, K. Owens, T.H. Thatcher, P.J. Sime, R.P. Phipps, Rochester, NY, p.A6130 2:30 Circadian Regulation of Lung Injury and Inflammation in Influenza A Infection/S. Sengupta, J. Xue, C.B. Lopez, G.A. FitzGerald, Philadelphia, PA, p.A6131 2:45 Transient Receptor Potential Vanilloid 4 (TRPV4) Mediates Macrophage Phagocytosis, Cytokine Production, and Infection-Associated Lung Injury/Resolution in a Stiffness Dependent Manner/R.G. Scheraga, S. Abraham, K.A. Niese, L.M. Grove, B.D. Southern, T.L. Bonfield, C. Zhao, T.A. Hamilton, M.A. Olman, Cleveland, OH, p.A6132 3:00 Viral Infection Induces Development of a Distinct Neutrophil Phenotype with Impaired Ability to Clear Bacterial Pathogens/J.E. Prasso, W. Lung, C. Yuen, Y. Tarabichi, Q. Cheng, J.C. Deng, Los Angeles, CA, p.A6133 3:15 Impaired Dendritic Cell Recruitment and Anti-viral Function in Asthmatic Patients Following Rhinovirus Infection/A. Cameron, J. Dhariwal, S.L. Johnston, R.P. Walton, London, United Kingdom, p.A6134 3:30 Resistin-Like Molecules as Antiviral Mediators Against Influenza A Virus Infection/A.E. Samarasinghe, Y. Lin, K. LeMessurier, J.A. McCullers, Memphis, TN, p.A6135 3:45 Resolution of Respiratory Pneumococcal Infection Seeds the Local Lung Tissue with CD4+ TRM Cells that Prevent Future Pneumonias/N.M.S. Stauffer, F.T. Coleman, K.L. Hilliard, K. Yamamoto, G. Wasserman, H. Dooms, M. Jones, L.J. Quinton, J.P. Mizgerd, Boston, MA, p.A6136 4:00 IL-33 Protects Against Influenza-Associated Bacterial Super-Infection/K.M. Robinson, M.E. Clay, K. Ramanan, K.J. McHugh, J.F. Alcorn, Pittsburgh, PA, p.A6137 C94 MINI SYMPOSIUM LUNG INJURY, INFLAMMATION AND REPAIR: INNATE IMMUNE REGULATION 2:15 p.m. - 4:15 p.m. MOSCONE CENTER Chairing: R. Vlahos, PhD, Bundoora, Australia R.L. Zemans, MD, Denver, CO Oral Presentations Room 2020/2022 (West Building, Level 2) 2:15 Pannexin-1 Channels on Endothelial Cells Regulate Lung Ischemia-Reperfusion Injury/A.K. Sharma, E. Charles, Y. Zhao, I. Kron, K.S. Ravichandran, B. Isakson, V. Laubach, Charlottesville, VA, p.A6138 2:30 Epithelial b1 Integrin is Required for Maintenance of Alveolar Homeostasis in the Adult Lung/E.J. Plosa, L.R. Young, T.S. Blackwell, R. Zent, Nashville, TN, p.A6139 2:45 Increased Expression of microRNA-155-5p by Alveolar Type II Cells Contributes to Development of ARDS in H1N1 Influenza A Virus-Infected Mice/I.C. Davis, P. Woods, E. Tili, L. Martinez-Sobrido, Columbus, OH, p.A6140 3:00 Group-2 Innate Lymphoid Cells Mediate Ozone Induced Neutrophilia and Airway Hyperresponsiveness/C.H. Flayer, M.Q. Ge, C.E. Jereb, S. Ott, Q. Yang, A. Haczku, Davis, CA, p.A6141 3:15 Type-2 Immune Responses Protect Against Bleomycin-Induced Lung Injury Through an ICOS-Dependent Mechanism/C.L. Hrusch, D. Bryaska, M. Jaffery, C. Bonham, K. Blaine, J. Casaos, S. Takahashi-Manns, A.I. Sperling, Chicago, IL, p.A6142 3:30 Foxp3+ Regulatory T Cell Expression of Keratinocyte Growth Factor During Acute Lung Injury Resolution/J.R. Mock, C.F. Dial, F.R. D’Alessio, C.M. Doerschuk, Chapel Hill, NC, p.A6143 3:45 Ozone Suppresses Pulmonary Dendritic Cell Migration to Regional Lymph Nodes Via SP-D and NKp46 Dependent Pathways/M.Q. Ge, B. Kokalari, C.H. Flayer, S.S. Killingbeck, I. Redai, A. Macfarlane, J.W. Hwang, A. Kolupoti, D.M. Kemeny, K.S. Campbell, A. Haczku, Davis, CA, p.A6144 4:00 Human Ex-Vivo Ventilated and Perfused Lungs: A Relevant Pre-Clinical Model for Therapeutic Testing of the Small Molecule Anti-Inflammatory FBXO3 Inhibitor BC1215/N. Weathington, D. Alvarez, J. Sembrat, N. Cardenes, K. Noda, Q. Gong, N. Shigemura, J. D’Cunha, B. Chen, R. Mallampalli, M. Rojas, Pittsburgh, PA, p.A6145 C95 MINI SYMPOSIUM OUTSTANDING EPIDEMIOLOGY AND HEALTH SERVICES RESEARCH IN CRITICAL CARE 2:15 p.m. - 4:15 p.m. MOSCONE CENTER Room 3003/3005 (West Building, Level 3) ATS 2016 • San Francisco
TUESDAY • MAY 17 321 Chairing: H. Wunsch, MD, MSc, Toronto, Canada A.J. Walkey, MD, MSc, Boston, MA Oral Presentations 2:15 The Critical Care Crisis of Opioid Overdoses in the U.S./J.P. Stevens, M.J. Wall, D. Hsu, J. Marshall, M.D. Howell, Boston, MA, p.A6146 2:30 Healthcare Utilization Patterns 12 Months Pre- and Post-ICU Admission/E. Hirshberg, K. Kuttler, V. Standfield, R.O. Hopkins, S.M. Brown, Salt Lake City, UT, p.A6147 2:45 Epidemiology of Vasopressin Use Among Adults with Septic Shock in the United States/E.A. Vail, H.B. Gershengorn, M. Hua, A.J. Walkey, H. Wunsch, New York, NY, p.A6148 3:00 Modeling Patient Subpopulations Improves Sepsis Mortality Prediction/A.P. Sales, M.B. Mayhew, J.D. Greene, J.M. Baker, A. Santucci, G.J. Escobar, T. Wasson, V. Liu, Livermore, CA, p.A6149 3:15 Nighttime Extubations Are Associated with Worse Outcomes for U.S. Intensive Care Unit Patients/H.B. Gershengorn, D.C. Scales, A. Kramer, H. Wunsch, Bronx, NY, p.A6150 3:30 Racial and Socioeconomic Disparities in Mortality Among Older Survivors of Critical Illness/M.R. Baldwin, J. Sell, W.C. Gonzalez, N. Hayden, A. Javaid, D. Berlin, D.J. Lederer, New York, NY, p.A6151 3:45 Clinical and Sociocultural Factors Causing In-Hospital Medical Emergencies: A Qualitative Study/F. Elmufdi, S. Burton, N. Sahni, C. Weinert, Minneapolis, MN, p.A6152 4:00 Reversal of Scientific Evidence and Identifying Opportunities for De-Adoption in Critical Care: A Scoping Review/D.J. Niven, T.J. McCormick, S. Straus, B. Hemmelgarn, L. Jeffs, T. Barnes, H.T. Stelfox, Calgary, Canada, p.A6153 2:45 The Morbidity, Mortality, and Healthcare Utilization Attributed to Cardiovascular Disease in COPD Patients in Quebec, Canada/R. Tavares, T. Dang-Tan, S. Zhang, A. Ismaila, M. Stutz, E.C. Goodall, D. Corriveau, R.H. Stanford, J. Vaillancourt, D. Parsons, X. Lin, A. Simidchiev, G. Nadeau, A.C. Lindsay, J.S. Sampalis, Mississauga, Canada, p.A6155 3:00 A Cross-Sectional Assessment of the Burden of Chronic Obstructive Pulmonary Disease (COPD) Symptoms in the United States and Europe using the National Health and Wellness Survey/B. Ding, M. DiBonaventura, N. Karlsson, G. Bergstrom, U. Holmgren, Gothenburg, Sweden, p.A6156 3:15 Evaluation of the Newly Developed Assessment of Burden COPD (ABC)-Tool: A Tool to Measure and Visualize the Experienced Burden of COPD Patients/A.H.M. Slok, D. Kotz, G. Van Breukelen, N.H. Chavannes, M.P.M.H. Rutten-van Molken, H. Kerstjens, T. Van Der Molen, G.M. Asijee, R.P. Dekhuijzen, S. Holverda, P.L. Salome, L.M. Goossens, J.C.C.M. In ‘t Veen, O.C.P. Van Schayck, Maastricht, Netherlands, p.A6157 3:30 Regional, Gender and Racial Variation in COPD Medication Prescribing Patterns in the US/A. Pandya, A. Kaur, J. Mamary, H. Zhao, M.R. Jacobs, G.J. Criner, Philadelphia, PA, p.A6158 3:45 Forecasting Health Services Use in Individuals with Chronic Obstructive Pulmonary Disease (COPD): A Time-Series Analysis/A.S. Gershon, D. Thiruchelvam, R. Moineddin, X.Y. Zhao, J. Hwee, T. To, Toronto, Canada, p.A6159 4:00 Optimizing Spirometric Assessment of COPD Classification and Prognosis/W. Checkley, R.A. Wise, J. Garcia-Aymerich, P. Sobradillo, G. Barr, P. Lange, N.N. Hansel, A. Agusti, R. Rodriguez-Roisin, J. Anto, A. Menezes, M.A. Puhan, Baltimore, MD, p.A6160 C96 MINI SYMPOSIUM GLOBAL PERSPECTIVES ON COPD BURDEN AND CARE DELIVERY 2:15 p.m. - 4:15 p.m. MOSCONE CENTER Chairing: J. Bourbeau, MD, Montreal, Canada J.A. Ohar, MD, Winston-Salem, NC S.R. Russell, MD, Chicago, IL Featured Speaker Room 130-132 (North Building, Lower Level) 2:15 COPD Care in the U.S.: A Special Report on Behalf of the Lancet Respiratory Medicine Commission/M.K. Han, MD, MS, Ann Arbor, MI, Oral Presentations 2:30 Organizational Factors Associated with Length of Stay for Veterans with Chronic Obstructive Pulmonary Disease/S. Rinne, L.A. Bastian, P.K. Lindenauer, P. Kaboli, M.A. Cook, E.S. Wong, C.-F. Liu, New Haven, CT, p.A6154 C97 MINI SYMPOSIUM COPD: EPIDEMIOLOGY, RISK FACTORS, AND BIOMARKERS 2:15 p.m. - 4:15 p.m. MOSCONE CENTER Chairing: R.G. Barr, MD, DrPH, New York, NY M.G. Foreman, MD, Atlanta, GA J.M. Brehm, MD, MPH, Pittsburgh, PA Oral Presentations Room 2002/2004 (West Building, Level 2) 2:15 Prevalence and Mortality of the Asthma-COPD Overlap Syndrome (ACOS) in Denmark: A Long-Term Follow-Up Study of a Large Random Population Sample/C.B. Barnes, Z.J. Andersen, K. Overvad, A. Tjonneland, C.S. Ulrik, Hvidovre, Denmark, p.A6161 2:30 Socioeconomic Status and Chronic Obstructive Pulmonary Disease Among Low- and Middle-Income Countries: The GRAND South Study/M. Grigsby, T. Siddharthan, W. Checkley, Baltimore, MD, p.A6162 TUESDAY AFTERNOON ATS 2016 • San Francisco
- Page 1 and 2:
American Thoracic Society Internati
- Page 3:
TABLE OF CONTENTS ATS 2016 INTERNAT
- Page 6 and 7:
2 FRIDAY • MAY 13 PG2A CLINICAL P
- Page 8 and 9:
4 FRIDAY • MAY 13 Target Audience
- Page 10 and 11:
6 FRIDAY • MAY 13 11:15 Case Disc
- Page 12 and 13:
8 FRIDAY • MAY 13 Chairing: H.B.
- Page 14 and 15:
10 FRIDAY • MAY 13 10:25 Advanced
- Page 16 and 17:
12 FRIDAY • MAY 13 Objectives At
- Page 18 and 19:
14 SATURDAY • MAY 14 Abdominal Ul
- Page 20 and 21:
16 SATURDAY • MAY 14 PG17 BASIC
- Page 22 and 23:
18 SATURDAY • MAY 14 1:05 In What
- Page 24 and 25:
20 SATURDAY • MAY 14 10:30 Practi
- Page 26 and 27:
22 SATURDAY • MAY 14 Objectives A
- Page 28 and 29:
24 SATURDAY • MAY 14 10:10 Is My
- Page 30 and 31:
26 SUNDAY • MAY 15 Chairing: D.M.
- Page 32 and 33:
28 SUNDAY • MAY 15 Chronic Cough:
- Page 34 and 35:
30 SUNDAY • MAY 15 • understand
- Page 36 and 37:
32 SUNDAY • MAY 15 Target Audienc
- Page 38 and 39:
34 SUNDAY • MAY 15 Oral Presentat
- Page 40 and 41:
36 SUNDAY • MAY 15 9:15 Hyperpola
- Page 42 and 43:
38 SUNDAY • MAY 15 310 A Smartpho
- Page 44 and 45:
40 SUNDAY • MAY 15 103 Immunosupp
- Page 46 and 47:
42 SUNDAY • MAY 15 A26 POSTER DIS
- Page 48 and 49:
44 SUNDAY • MAY 15 822 Incidence
- Page 50 and 51:
46 SUNDAY • MAY 15 519 Maternal H
- Page 52 and 53:
48 SUNDAY • MAY 15 P14 P15 P16 P1
- Page 54 and 55:
50 SUNDAY • MAY 15 P1545 P1546 Fa
- Page 56 and 57:
52 SUNDAY • MAY 15 P60 P61 Facili
- Page 58 and 59:
54 SUNDAY • MAY 15 P149 P150 Faci
- Page 60 and 61:
56 SUNDAY • MAY 15 P749 P750 P751
- Page 62 and 63:
58 SUNDAY • MAY 15 Facilitator: P
- Page 64 and 65:
60 SUNDAY • MAY 15 P1243 P1244 P1
- Page 66 and 67:
62 SUNDAY • MAY 15 P1295 P1296 P1
- Page 68 and 69:
64 SUNDAY • MAY 15 P1358 P1359 P1
- Page 70 and 71:
66 SUNDAY • MAY 15 P91 Facilitato
- Page 72 and 73:
68 SUNDAY • MAY 15 P616 P617 P618
- Page 74 and 75:
70 SUNDAY • MAY 15 P914 P915 P916
- Page 76 and 77:
72 SUNDAY • MAY 15 P556 P557 P558
- Page 78 and 79:
74 SUNDAY • MAY 15 Facilitators:
- Page 80 and 81:
76 SUNDAY • MAY 15 P997 P998 P999
- Page 82 and 83:
78 SUNDAY • MAY 15 P256 P257 P258
- Page 84 and 85:
80 SUNDAY • MAY 15 A61 THEMATIC P
- Page 86 and 87:
82 SUNDAY • MAY 15 P824 Facilitat
- Page 88 and 89:
84 SUNDAY • MAY 15 P1055 P1056 P1
- Page 90 and 91:
86 SUNDAY • MAY 15 P1101 P1102 P1
- Page 92 and 93:
88 SUNDAY • MAY 15 P1423 P1424 P1
- Page 94 and 95:
90 SUNDAY • MAY 15 P1474 P1475 P1
- Page 96 and 97:
92 SUNDAY • MAY 15 P377 P378 P379
- Page 98 and 99:
94 SUNDAY • MAY 15 P281 P282 P283
- Page 100 and 101:
96 SUNDAY • MAY 15 P450 P451 A74
- Page 102 and 103:
98 SUNDAY • MAY 15 P1562 P1563 P1
- Page 104 and 105:
100 SUNDAY • MAY 15 A80-A THEMATI
- Page 106 and 107:
102 SUNDAY • MAY 15 Facilitator:
- Page 108 and 109:
104 SUNDAY • MAY 15 11:00 a.m.-12
- Page 110 and 111:
106 SUNDAY • MAY 15 L1 U.S. FOOD
- Page 112 and 113:
108 SUNDAY • MAY 15 12:15 Post-Pr
- Page 114 and 115:
110 SUNDAY • MAY 15 MP406 MP407 M
- Page 116 and 117:
112 SUNDAY • MAY 15 clinician and
- Page 118 and 119:
114 SUNDAY • MAY 15 A86 BASIC •
- Page 120 and 121:
116 SUNDAY • MAY 15 Chairing: M.J
- Page 122 and 123:
118 SUNDAY • MAY 15 3:30 High Pre
- Page 124 and 125:
120 SUNDAY • MAY 15 102 Toll-Like
- Page 126 and 127:
122 SUNDAY • MAY 15 A103 POSTER D
- Page 128 and 129:
124 SUNDAY • MAY 15 719 Lactate R
- Page 130 and 131:
126 SUNDAY • MAY 15 1014 Determin
- Page 132 and 133:
128 SUNDAY • MAY 15 611 Plasma Mi
- Page 134 and 135:
130 SUNDAY • MAY 15 412 Daytime S
- Page 136 and 137:
132 SUNDAY • MAY 15 6:30 p.m. - 8
- Page 138 and 139:
134 MONDAY • MAY 16 SS111 SS112 S
- Page 140 and 141:
136 MONDAY • MAY 16 Target Audien
- Page 142 and 143:
138 MONDAY • MAY 16 9:40 Empoweri
- Page 144 and 145:
140 MONDAY • MAY 16 9:28 Endotoxi
- Page 146 and 147:
142 MONDAY • MAY 16 10:15 Adaptiv
- Page 148 and 149:
144 MONDAY • MAY 16 Oral Presenta
- Page 150 and 151:
146 MONDAY • MAY 16 624 Neonatal
- Page 152 and 153:
148 MONDAY • MAY 16 118 Compariso
- Page 154 and 155:
150 MONDAY • MAY 16 912 Should Pa
- Page 156 and 157:
152 MONDAY • MAY 16 1015 Resverat
- Page 158 and 159:
154 MONDAY • MAY 16 718 Health Re
- Page 160 and 161:
156 MONDAY • MAY 16 P152 Facilita
- Page 162 and 163:
158 MONDAY • MAY 16 B35 THEMATIC
- Page 164 and 165:
160 MONDAY • MAY 16 P252 P253 P25
- Page 166 and 167:
162 MONDAY • MAY 16 P406 P407 P40
- Page 168 and 169:
164 MONDAY • MAY 16 P320 Bilatera
- Page 170 and 171:
166 MONDAY • MAY 16 B40 THEMATIC
- Page 172 and 173:
168 MONDAY • MAY 16 P528 P529 Fac
- Page 174 and 175:
170 MONDAY • MAY 16 Facilitator:
- Page 176 and 177:
172 MONDAY • MAY 16 B44 THEMATIC
- Page 178 and 179:
174 MONDAY • MAY 16 P484 P485 P48
- Page 180 and 181:
176 MONDAY • MAY 16 P1161 P1162 P
- Page 182 and 183:
178 MONDAY • MAY 16 B48 THEMATIC
- Page 184 and 185:
180 MONDAY • MAY 16 P1238 P1239 P
- Page 186 and 187:
182 MONDAY • MAY 16 P1297 P1298 P
- Page 188 and 189:
184 MONDAY • MAY 16 Facilitator:
- Page 190 and 191:
186 MONDAY • MAY 16 P15 P16 P17 P
- Page 192 and 193:
188 MONDAY • MAY 16 Facilitator:
- Page 194 and 195:
190 MONDAY • MAY 16 P114 P115 P11
- Page 196 and 197:
192 MONDAY • MAY 16 P1408 Enhance
- Page 198 and 199:
194 MONDAY • MAY 16 P1455 P1456 P
- Page 200 and 201:
196 MONDAY • MAY 16 P1487 P1488 P
- Page 202 and 203:
198 MONDAY • MAY 16 P1514 P1515 P
- Page 204 and 205:
200 MONDAY • MAY 16 Facilitator:
- Page 206 and 207:
202 MONDAY • MAY 16 P559 P560 P56
- Page 208 and 209:
204 MONDAY • MAY 16 WS3 CLINICAL
- Page 210 and 211:
206 MONDAY • MAY 16 Satellite ear
- Page 212 and 213:
208 MONDAY • MAY 16 Objectives At
- Page 214 and 215:
210 MONDAY • MAY 16 encourage tra
- Page 216 and 217:
212 MONDAY • MAY 16 B82 BEHAVIORA
- Page 218 and 219:
214 MONDAY • MAY 16 B86 BASIC •
- Page 220 and 221:
216 MONDAY • MAY 16 and a number
- Page 222 and 223:
218 MONDAY • MAY 16 2:30 Mortalit
- Page 224 and 225:
220 MONDAY • MAY 16 3:00 Simultan
- Page 226 and 227:
222 MONDAY • MAY 16 525 Clinical
- Page 228 and 229:
224 MONDAY • MAY 16 320 Sensitivi
- Page 230 and 231:
226 MONDAY • MAY 16 113 COPD Subt
- Page 232 and 233:
228 MONDAY • MAY 16 1004 Health C
- Page 234 and 235:
230 MONDAY • MAY 16 609 Skeletal
- Page 236 and 237:
232 MONDAY • MAY 16 5:00 p.m. - 7
- Page 238 and 239:
234 TUESDAY • MAY 17 Chairing: D.
- Page 240 and 241:
236 TUESDAY • MAY 17 CLINICAL YEA
- Page 242 and 243:
238 TUESDAY • MAY 17 This session
- Page 244 and 245:
240 TUESDAY • MAY 17 bronchiectas
- Page 246 and 247:
242 TUESDAY • MAY 17 Target Audie
- Page 248 and 249:
244 TUESDAY • MAY 17 C18 MINI SYM
- Page 250 and 251:
246 TUESDAY • MAY 17 415 Investig
- Page 252 and 253:
248 TUESDAY • MAY 17 207 Survival
- Page 254 and 255:
250 TUESDAY • MAY 17 906 Phenotyp
- Page 256 and 257:
252 TUESDAY • MAY 17 807 The Vali
- Page 258 and 259:
254 TUESDAY • MAY 17 515 Roles of
- Page 260 and 261:
256 TUESDAY • MAY 17 P383 P384 P3
- Page 262 and 263:
258 TUESDAY • MAY 17 Facilitator:
- Page 264 and 265:
260 TUESDAY • MAY 17 P199 P200 P2
- Page 266 and 267:
262 TUESDAY • MAY 17 P620 Facilit
- Page 268 and 269:
264 TUESDAY • MAY 17 P428 P429 P4
- Page 270 and 271:
266 TUESDAY • MAY 17 P442 P443 P4
- Page 272 and 273:
268 TUESDAY • MAY 17 P318 P319 P3
- Page 274 and 275: 270 TUESDAY • MAY 17 P474 P475 Fa
- Page 276 and 277: 272 TUESDAY • MAY 17 Facilitator:
- Page 278 and 279: 274 TUESDAY • MAY 17 P727 P728 P7
- Page 280 and 281: 276 TUESDAY • MAY 17 P774 P775 Fa
- Page 282 and 283: 278 TUESDAY • MAY 17 C53 THEMATIC
- Page 284 and 285: 280 TUESDAY • MAY 17 C55 THEMATIC
- Page 286 and 287: 282 TUESDAY • MAY 17 P1095 P1096
- Page 288 and 289: 284 TUESDAY • MAY 17 P1167 P1168
- Page 290 and 291: 286 TUESDAY • MAY 17 P632 P633 P6
- Page 292 and 293: 288 TUESDAY • MAY 17 P546 P547 P5
- Page 294 and 295: 290 TUESDAY • MAY 17 Facilitator:
- Page 296 and 297: 292 TUESDAY • MAY 17 C65 THEMATIC
- Page 298 and 299: 294 TUESDAY • MAY 17 P659 P660 P6
- Page 300 and 301: 296 TUESDAY • MAY 17 P1506 P1507
- Page 302 and 303: 298 TUESDAY • MAY 17 C70 THEMATIC
- Page 304 and 305: 300 TUESDAY • MAY 17 P1363 P1364
- Page 306 and 307: 302 TUESDAY • MAY 17 P928 P929 P9
- Page 308 and 309: 304 TUESDAY • MAY 17 P973 P974 Fa
- Page 310 and 311: 306 TUESDAY • MAY 17 Facilitator:
- Page 312 and 313: 308 TUESDAY • MAY 17 C80 THEMATIC
- Page 314 and 315: 310 TUESDAY • MAY 17 P98 P99 P100
- Page 316 and 317: 312 TUESDAY • MAY 17 • become a
- Page 318 and 319: 314 TUESDAY • MAY 17 The topics a
- Page 320 and 321: 316 TUESDAY • MAY 17 C85 BASIC
- Page 322 and 323: 318 TUESDAY • MAY 17 C89 BASIC
- Page 326 and 327: 322 TUESDAY • MAY 17 2:45 Long-Te
- Page 328 and 329: 324 TUESDAY • MAY 17 918 Sarcoido
- Page 330 and 331: 326 TUESDAY • MAY 17 410 Effectiv
- Page 332 and 333: 328 TUESDAY • MAY 17 710 Follista
- Page 334 and 335: 330 TUESDAY • MAY 17 509 A Mechan
- Page 336 and 337: 332 TUESDAY • MAY 17 806 Upper Ai
- Page 338 and 339: 334 WEDNESDAY • MAY 18 6:45 Acute
- Page 340 and 341: 336 WEDNESDAY • MAY 18 CLINICAL Y
- Page 342 and 343: 338 WEDNESDAY • MAY 18 Objectives
- Page 344 and 345: 340 WEDNESDAY • MAY 18 D9 BASIC
- Page 346 and 347: 342 WEDNESDAY • MAY 18 Oral Prese
- Page 348 and 349: 344 WEDNESDAY • MAY 18 10:15 Plas
- Page 350 and 351: 346 WEDNESDAY • MAY 18 419 A Nove
- Page 352 and 353: 348 WEDNESDAY • MAY 18 216 Simpli
- Page 354 and 355: 350 WEDNESDAY • MAY 18 815 Multip
- Page 356 and 357: 352 WEDNESDAY • MAY 18 D28 POSTER
- Page 358 and 359: 354 WEDNESDAY • MAY 18 720 Repeat
- Page 360 and 361: 356 WEDNESDAY • MAY 18 P389 Facil
- Page 362 and 363: 358 WEDNESDAY • MAY 18 P439 P440
- Page 364 and 365: 360 WEDNESDAY • MAY 18 P10 P11 P1
- Page 366 and 367: 362 WEDNESDAY • MAY 18 P52 P53 Fa
- Page 368 and 369: 364 WEDNESDAY • MAY 18 P95 P96 P9
- Page 370 and 371: 366 WEDNESDAY • MAY 18 P698 P699
- Page 372 and 373: 368 WEDNESDAY • MAY 18 D42 THEMAT
- Page 374 and 375:
370 WEDNESDAY • MAY 18 P748 Funge
- Page 376 and 377:
372 WEDNESDAY • MAY 18 P353 P354
- Page 378 and 379:
374 WEDNESDAY • MAY 18 P172 P173
- Page 380 and 381:
376 WEDNESDAY • MAY 18 P808 Facil
- Page 382 and 383:
378 WEDNESDAY • MAY 18 P526 P527
- Page 384 and 385:
380 WEDNESDAY • MAY 18 P579 P580
- Page 386 and 387:
382 WEDNESDAY • MAY 18 P944 P945
- Page 388 and 389:
384 WEDNESDAY • MAY 18 P991 P992
- Page 390 and 391:
386 WEDNESDAY • MAY 18 P1036 P103
- Page 392 and 393:
388 WEDNESDAY • MAY 18 P1062 P106
- Page 394 and 395:
390 WEDNESDAY • MAY 18 11:45 Intr
- Page 396 and 397:
392 WEDNESDAY • MAY 18 12:15 Upda
- Page 398 and 399:
394 WEDNESDAY • MAY 18 This sessi
- Page 400 and 401:
396 WEDNESDAY • MAY 18 1:30 The B
- Page 402 and 403:
398 WEDNESDAY • MAY 18 D88 BEHAVI
- Page 404 and 405:
400 WEDNESDAY • MAY 18 3:00 Accel
- Page 406 and 407:
402 WEDNESDAY • MAY 18 D96 MINI S
- Page 408 and 409:
404 WEDNESDAY • MAY 18 604 CARMA3
- Page 410 and 411:
406 WEDNESDAY • MAY 18 702 Potent
- Page 412 and 413:
408 WEDNESDAY • MAY 18 803 ICU Ac
- Page 414 and 415:
410 WEDNESDAY • MAY 18 Chairing:
- Page 416 and 417:
412 WEDNESDAY • MAY 18 404 Interm
- Page 418:
Where today’s science meets tomor